Superiority of the DNA amplification assay for the diagnosis of c. difficile infection: A clinical comparison of fecal tests

Digestive Diseases and Sciences

Volumn 57, Issue 10, 2012, Pages 2592-2599

  Barkin, Jodie A ^a   Nandi, Neilanjan ^a   Miller, Nancimae ^b   Grace, Alexandra ^b   Barkin, Jamie S ^a,b   Sussman, Daniel A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Clostridium difficile; Diagnosis; DNA amplification; Immunoenzyme assays

Indexed keywords

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; ELECTRONIC MEDICAL RECORD; FECES ANALYSIS; GENE AMPLIFICATION; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NURSING HOME; PARAMETERS; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TOXIN ANALYSIS;

AGED; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DNA, BACTERIAL; ENTEROTOXINS; FECES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GLUTAMATE DEHYDROGENASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84867879612     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2200-x     Document Type: Article

References (22)

1. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile related hospitalizations and case-fatality rate, United States 2000-2005. Emerg Infect Dis. 2008;14:929-931.
2. Kyne L, Hamel MB, Plavaram R, et al. Healthcare costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346-353.
3. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors, and management. Nat Rev Gastroenterol Hepatol. 2011;8:17-26.
4. U.S. Department of Health and Human Services. HCUPnet [online]. Available at: http://hcupnet.ahrq.gov/. Accessed 2010.
5. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile and C. difficile infection. Infect Control Hosp Epidemiol. 2009;30:57-66.
6. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea, and colitis. World J Gastroenterol. 2009;15:1554-1580.
7. Carroll KC, Bartlett JG. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Ann Rev Microbiol. 2011;65:501-521.
8. Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev. 2008;32:541-555.
9. Doing KM, Hintz MS, Keefe C, et al. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluation Bartels cytotoxin and ProdeseProGastro Cd polymerase chain reaction as confirmatory procedures. Diagn Microbiol Infect Dis. 2010;66:129-134.
10. Larson AM, Fung AM, Fang FC. Evaluation of the tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol. 2010;48:124-130.
11. Kvach EJ, Ferguson D, Riska PF, et al. Comparison of BD GeneOhmCdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol. 2010;48:109-114.
12. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis. 2007;45:1152-1160.
13. Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47:373-378.
14. Stamper PD, Babiker W, Alcabasa R, et al. Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J Clin Microbiol. 2009;47:3846-3850.
15. Sloan LM, Duresko BJ, Gustafson DR, et al. Comparison of a real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol. 2008;46:1996-2001.
16. Barbut F, Braun M, Burghoffer B, et al. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol. 2009;47:1276-1277.
17. Eastwood K, Else P, Charlett A, et al. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47: 3211-3217.
18. Novak-Weekley SM, Marlowe EM, Miller JM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol. 2010;48:889-893.
19. Meridian Bioscience. Meridian illumigene assay package insert and product information. Available at: http://www.meridianbio science.com/diagnostic- products/c-difficile/illumigene-moleculardiagnostic- system/illumigene-c- difficile. 2011. Accessed 19 Oct 2011.
20. Currie B. Real-time PCR testing for CDI improves outcomes and reduces costs. MLO Med Lab Obs. 2009;41:18-20.
21. Mellow M, Kanatzar A, Brandt L, et al. Long term follow-up of colonoscopic fecal microbiota transplant (FMT) for recurrent C. difficile infection (RCDI). Podium Presentation at American College of Gastroenterology 2011 National Meeting. Washington, DC.
22. Loo VG, Bourgault A, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Eng J Med. 2011;365:1693-1703.